Exponential sum approximations for t−βt^{-\beta}

Given $\beta>0$ and $\delta>0$, the function $t^{-\beta}$ may be approximated for $t$ in a compact interval $[\delta,T]$ by a sum of terms of the form $we^{-at}$, with parameters $w>0$ and $a>0$. One such an approximation, studied by Beylkin and Monz\'on, is obtained by applying the trapezoidal rule to an integral representation of $t^{-\beta}$, after which Prony's method is applied to reduce the number of terms in the sum with essentially no loss of accuracy. We review this method, and then describe a similar approach based on an alternative integral representation. The main difference is that the new approach achieves much better results before the application of Prony's method; after applying Prony's method the performance of both is much the same.Comment: 18 pages, 5 figures. I have completely rewritten this paper because after uploading the previous version I realised that there is a much better approach. Note the change to the title. Have included minor corrections following revie

Ethics, Genetic Technologies and Equine Sports: The Prospect of Regulation of a Modified Therapeutic Use Exemption Policy

This article critically reviews the current availability and selected use of genetic technologies for horses, before undertaking an ethical evaluation of current practice and regulatory positions in comparative relation to debates surrounding genetic testing, pre-implantation genetic testing and gene editing in humans. We argue that genetic testing for hereditary disorders is not only justified but should be encouraged on welfare grounds and that genetic testing for performance traits is ethically permissible based on a restricted imperative to genetically edit horses and horse embryos to reduce genetic predisposition to disease and injury. Given the current state of the science, where the effects of gene editing on health and welfare are currently undetermined, space is created for an analytical distinction between equine gene editing for ‘treatment’ and for ‘enhancement’. Gene editing is only justified for purposes of correcting/preventing disease and injury. Current regulation is challenged by apparently conflicting welfare-based ethical imperatives with respect to welfare-based gene editing. We propose modifications to the blanket bans on gene editing with a case-by-case assessment of applications to permit gene editing, based on best welfare interests underwritten by the aim of facilitating fair sport that adapt WADAs International Standard for Therapeutic Use Exemptions, adding an important reporting element. We reject the use of gene editing to obtain currently prohibited competitive advantages. In order to safeguard the welfare of human and equine athletes, we argue that regulatory institutions should urgently collaborate to develop cross-sport international regulations for the use of gene editing, including obligatory reporting of data about the health and welfare of genetically edited horses

Ethics, evidence based sports medicine, and the use of platelet rich plasma in the English Premier League

The use of platelet rich plasma (PRP) as a novel treatment is discussed in the context of a qualitative research study comprising 38 interviews with sports medicine practitioners and other stakeholders working within the English Premier League during the 2013-16 seasons. Analysis of the data produced several overarching themes: conservatism versus experimentalism in medical attitudes; therapy perspectives divergence; conflicting versions of appropriate evidence; subcultures; community beliefs/practices; and negotiation of medical decision-making. The contested evidence base for the efficacy of PRP is presented in the context of a broader professional shift towards evidence based medicine within sports medicine. Many of the participants while accepting this shift are still committed to casuistic practices where clinical judgment is flexible and does not recognize a context-free hierarchy of evidentiary standards to ethically justifiable practice. We also discuss a tendency in the data collected to consider the use of deceptive, placebo-like, practices among the clinician participants that challenge dominant understandings of informed consent in medical ethics. We conclude that the complex relation between evidence and ethics requires greater critical scrutiny for this emerging specialism within the medical community

Real Lives: findings from the All-Ireland Gay Men’s Sex Surveys, 2003 and 2004

Duration: March 2000 - September 2010 Sigma Research has been working with Ireland's Gay Health Network (GHN) since 2000. GHN is an umbrella organisation working towards gay men's health and HIV prevention. GHN instigated a community-based, self-completion survey to take place across The Republic of Ireland and Northern Ireland during the summer of 2000 and commissioned Sigma Research to work with them. This large-scale community research project was the third such survey among gay men in Ireland, and built on previous findings. After the development and piloting of the survey, recruitment commenced at Dublin Pride in June 2000 and continued throughout the summer at similar events in Belfast, Derry, Galway, Limerick and Waterford. Recruitment in bars and clubs took place in Dublin and Cork, and social groups in more rural area were sent copies of the questionnaire and a request to distribute them to their members. 1,290 questionnaires were returned by gay men (81%), bisexual men (11%) and other homosexually active men living in Ireland. 19% of all respondents lived in Northern Ireland. A full survey report, including implications for HIV prevention planning is available to download. Since 2003 Gay Health Network members - particularly The Gay Men's Health Service (Health Services Executive) and the Rainbow Project, Northern Ireland - have collaborated with our online UK version of the Gay Men’s Sex Survey (Vital Statistics) by promoting it to men in Ireland via community websites and postcards distributed on the gay scene

Structural and individual costs of residential aged care services in Australia. The Resource Utilisation and Classification Study: Report 3

The Australian Health Services Research Institute (AHSRI), University of Wollongong, was commissioned by the Commonwealth Department of Health (the Department) in August 2017 to undertake the ‘Resource Utilisation and Classification Study’ (RUCS). The RUCS is an important national study commissioned by the Department to inform the development of future funding models for residential aged care in Australia. The purpose of the analysis covered in this report is to identify the drivers of care related costs that are fixed for residential aged care facilities. These are costs that relate to the characteristics of facilities rather than the care needs of individual residents. This study was the second of four separate but interrelated and overlapping studies undertaken to inform the design and implementation strategies for future funding reforms in the Australian residential aged care sector

Structural and individual costs of residential aged care services in Australia. The Resource Utilisation and Classification Study: Report 3

The Australian Health Services Research Institute (AHSRI), University of Wollongong, was commissioned by the Commonwealth Department of Health (the Department) in August 2017 to undertake the ‘Resource Utilisation and Classification Study’ (RUCS). The RUCS is an important national study commissioned by the Department to inform the development of future funding models for residential aged care in Australia. The purpose of the analysis covered in this report is to identify the drivers of care related costs that are fixed for residential aged care facilities. These are costs that relate to the characteristics of facilities rather than the care needs of individual residents. This study was the second of four separate but interrelated and overlapping studies undertaken to inform the design and implementation strategies for future funding reforms in the Australian residential aged care sector

Study on Doping Prevention: A map of Legal, Regulatory and Prevention Practice Provisions in EU 28

Historically, anti-doping efforts have focused on the detection and deterrence of doping in elite and competitive sport. There is, however, a growing concern that doping is occurring outside the organised sporting system; giving rise to the belief that the misuse of doping agents in recreational sport has become a societal problem and a public health issue that must be addressed. The EU Commission awarded a contract (EAC/2013/0617) to a Consortium to undertake this Study with the aim of developing the evidence-base for policies designed to combat doping in recreational sport. Fourteen internationally recognised experts shaped the Study which comprised (i) the collection of primary data through a structured survey, and (ii) secondary data through literature searches and website analysis. All 28 Member States participated in the information-gathering process. Specifically, this involved a systematic study of the ethical considerations, legal position, prevention research landscape, and current practise in relation to the prevention of doping in recreational sport. The Study provides a comprehensive overview of current practice and legislation as it applies to the prevention of doping and promotes and supports the sharing of best practices in the EU regarding the fight against doping in recreational sport. It concludes with seven recommendations for future action that focus on the need for a coordinated response in relation to the problems arising from doping in recreational sport

Pharmacist-led management of chronic pain in primary care:results from a randomised controlled exploratory trial

To compare the effectiveness of pharmacist medication review, with or without pharmacist prescribing, with standard care, for patients with chronic pain